Biopharmaceutical company
AI-generated insights about Praxis Precision Medicines, Inc. from various financial sources
Host responded enthusiastically to a suggestion for an 'ultra short' on the stock, which is planning a public offering that can cause share dilution.
Host responded enthusiastically to a suggestion for an 'ultra short' on the stock, which is planning a public offering that can cause share dilution.